Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome.
Inanc N, Kostov B, Priori R, Flores-Chavez A, Carubbi F, Szántó A, Valim V, Bootsma H, Praprotnik S, Fernandes Moça Trevisani V, Hernández-Molina G, Hofauer B, Pasoto SG, López-Dupla M, Bartoloni E, Rischmueller M, Devauchelle-Pensec V, Abacar K, Giardina F, Alunno A, Fanny Horváth I, de Wolff L, Caldas L, Retamozo S, Ramos-Casals M, Brito-Zerón P; Sjögren Big Data Consortium. Inanc N, et al. Among authors: de wolff l. Clin Exp Rheumatol. 2022 Dec;40(12):2290-2297. doi: 10.55563/clinexprheumatol/dt6klo. Epub 2022 Nov 17. Clin Exp Rheumatol. 2022. PMID: 36441656 Free article.
Ten years of the ESSDAI: is it fit for purpose?
de Wolff L, Arends S, van Nimwegen JF, Bootsma H. de Wolff L, et al. Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):283-290. Epub 2020 Oct 23. Clin Exp Rheumatol. 2020. PMID: 33095151 Free article. Review.
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren's syndrome.
de Wolff L, Arends S, Pontarini E, Bombardieri M, Bowman SJ, Bootsma H. de Wolff L, et al. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):100-106. doi: 10.55563/clinexprheumatol/i8g5nd. Epub 2021 Nov 10. Clin Exp Rheumatol. 2021. PMID: 34796851 Free article. Clinical Trial.
Differences in presentation between paediatric- and adult-onset primary Sjögren's syndrome patients.
Legger GE, Erdtsieck MB, de Wolff L, Stel AJ, Los LI, Verstappen GM, Spijkervet FKL, Vissink A, van der Vegt B, Kroese FGM, Armbrust W, Arends S, Bootsma H. Legger GE, et al. Among authors: de wolff l. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):85-92. doi: 10.55563/clinexprheumatol/vxe6h0. Epub 2021 Nov 10. Clin Exp Rheumatol. 2021. PMID: 34796855 Free article.
Long-term abatacept treatment for 48 weeks in patients with primary Sjögren's syndrome: The open-label extension phase of the ASAP-III trial.
de Wolff L, van Nimwegen JF, Mossel E, van Zuiden GS, Stel AJ, Majoor KI, Olie L, Los LI, Vissink A, Spijkervet FKL, Verstappen GMPJ, Kroese FGM, Arends S, Bootsma H. de Wolff L, et al. Semin Arthritis Rheum. 2022 Apr;53:151955. doi: 10.1016/j.semarthrit.2022.151955. Epub 2022 Jan 10. Semin Arthritis Rheum. 2022. PMID: 35091325 Free article. Clinical Trial.
Immunisation with Coronavirus-2 vaccines induces potent antibody responses and does not aggravate the lymphocyte compartment of primary Sjögren's syndrome patients.
Steinmetz TD, de Wolff L, Terpstra JH, Visser A, Bootsma H, Kroese FGM, Verstappen GM. Steinmetz TD, et al. Among authors: de wolff l. Clin Exp Rheumatol. 2022 Dec;40(12):2338-2343. doi: 10.55563/clinexprheumatol/1iaqnu. Epub 2022 Sep 5. Clin Exp Rheumatol. 2022. PMID: 36063118 Free article.
25 results